Highbridge Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,225,040
| Closed | -$11.9M | – | 559 |
|
|
2022
Q3 | $11.9M | Buy |
1,225,040
+100,609
| +9% | +$981K | 0.17% | 161 |
|
|
2022
Q2 | $10.9M | Hold |
1,124,431
| – | – | 0.25% | 140 |
|
|
2022
Q1 | $10.9M | Hold |
1,124,431
| – | – | 0.25% | 113 |
|
|
2021
Q4 | $10.9M | Hold |
1,124,431
| – | – | 0.24% | 143 |
|
|
2021
Q3 | $10.9M | Buy |
+1,124,431
| New | +$10.9M | 0.29% | 112 |
|